Biotie appoints new CFO
This article was originally published in Scrip
Executive Summary
Turku, Finland-based Biotie Therapies, a company developing drugs for neurodegenerative and psychiatric disorders like Alzheimer's disease and Parkinson's disease, has named David Cook as its new chief financial officer, effective from 25 February 2013.